Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1951;4:416-419

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEVINSON, D. C.
Right arrow Articles by Troutman, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEVINSON, D. C.
Right arrow Articles by Troutman, M. F.

(Circulation. 1951;4:416.)
© 1951 American Heart Association, Inc.


Evaluation of Anticoagulant Therapy in Congestive Heart Failure

DAVID C. LEVINSON M.D.1; GEORGE C. GRIFFITH M.D.1; Mary F. Troutman B.A.1

1 From the School of Medicine, Department of Medicine (Cardiology), University of Southern California, and the Los Angeles County Hospital, Los Angeles, Calif.

A one year study evaluating anticoagulant drugs as an adjunct in the management of congestive heart failure has been carried out on 300 patients. Depo-Heparin and dicumarol were the drugs employed. The effect of anticoagulant therapy upon the incidence of thromboembolic complications and mortality has been studied.